VEGF found to prolong survival of stem cells
A team of researchers have developed a new technology, which is promising to understand and treat ischemic diseases...
List view / Grid view
News
Exclusive speaker interview with Professor Nagy Habib – MiNA Therapeutics/Imperial College London
SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!
Ancient antiviral response could help treat cancer
By stimulating a patient’s immune system, a drug already in use to treat a blood disorder can prevent the growth of a variety of solid tumours...
Scientists identify new treatment for Activated PI3-kinase Delta Syndrome
Scientists have identified a new treatment approach for patients with a rare inherited immune disorder...
Scientists create “tracking” nanoagents to illuminate very small diseased tissues
Polymer nanoagents that can ‘light up’ tiny areas of diseased tissues that conventional methods fail to detect, have been created by a research team led by NTU Singapore.
DNA analysis incorporated into antenatal screening to test for chromosome disorders
Scientists have shown that it is possible to incorporate DNA analysis into antenatal screening for three serious chromosome disorders including Down's syndrome...
Researchers produce the first draft cell atlas of the small intestine
By surveying gene expression, researchers have created a reference atlas for understanding the biology of inflammatory bowel disease and food allergies, among other conditions...
FDG PET shows tumour DNA levels in blood are linked to NSCLC
Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
Selective PDE4D inhibitor shows potential to treat Fragile X syndrome
Preclinical research suggests the potential utility of BPN14770, as a prospective treatment for Alzheimer's disease...
LXB4 lipid protect neurons against glaucoma
Researchers have identified a new neuroprotective factor that has the potential to help people suffering from glaucoma...
Charles River Laboratories presents newly expanded capabilities at Neuroscience 2017
Charles River Laboratories International, Inc. announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at Neuroscience 2017, the 47th annual meeting of the Society for Neuroscience (SfN).
SORLA protein protects against Alzheimer’s disease
Researchers have identified a new protective function for a brain protein genetically linked to Alzheimer's...
Stem cells pave the way for new treatment of diabetes
A new study has shown how human stem cells can produce insulin-producing cells that in the future can be transplanted into diabetes patients...
New techniques give blood biopsies greater promise
Improved methods validate the use of blood samples for studying patients' cancer genomes
Potential new treatment for Fragile X targets one gene to affect many
Inhibitors of chromatin remodelling proteins may be a potential treatment for Fragile X Syndrome...
